HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2170285Generated: October 29, 2026
Water → 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one hydrate
https://huagongshe.com/reaction/2170285
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Aripiprazole | HCID 60795 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one hydrate | HCID 11408688 | — |
Reaction Steps
The resulting crude aripiprazole (aripiprazole anhydrous crystal) was added to water-containing ethanol (ethanol: 80%, water: 20%), and heated to a solvent reflux temperature to completely dissolve the crude aripiprazole. The solution was cooled to precipitate an aripiprazole hydrate crystal, and the aripiprazole hydrate crystal was precipitated and milled by a wet pulverization device. After the solvent was removed by filtration, drying (air-drying overnight at room temperature) was performed to obtain an aripiprazole hydrate fine crystal (a crystal of aripiprazole hydrate A). The particle size was adjusted by wet pulverization operation conditions (suspension temperature, rotation speed, shape of wings for pulverization, etc.) to prepare a crystal of aripiprazole hydrate A having a desired particle size.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09051268B2 |
|---|
| Source dataset | uspto-grants-2015_06 |
|---|
| ORD ID | ord-7b1e8b7040d94221b4920a6ca5eb3898 |
|---|
| Source note | uspto-grants-2015_06 |
|---|